However, ASCT2 deletion in two human cancer cell lines did not abolish the cell growth inhibition by compound 38 or other ASCT2 inhibitors belonging to the same 2-amino-4-bis(aryloxybenzyl) aminobutanoic acid (AABA) class. This evidence concerns the gene SLC1A5 and cancer.